Characteristics of Medication Use During Pediatric Medical Emergency Team Events and the Role of a Pharmacist-Provided Medication Supply

Melania M. Bembea,Kristine A. Rapan Parbuoni,Karen P. Zimmer,Michael A. Veltri,Nicole A. Shilkofski,Kristen McMillan-Nelson,Carlton K.K. Lee,Elizabeth A. Hunt
DOI: https://doi.org/10.5863/1551-6776-17.3.236
2012-12-01
The Journal of Pediatric Pharmacology and Therapeutics
Abstract:OBJECTIVES To determine the type and frequency of and indications for medications used during pediatric medical emergency team (PMET) events and to describe a PMET pharmacist training model, creation of a standardized “pharmacist PMET supply,” and the pharmacist's role in implementation and ongoing improvement of a PMET. METHODS This is a retrospective observational cohort study of 210 PMET events in 172 patients in a tertiary care, academic pediatric hospital, from September 15, 2005, to September 15, 2007. We focused on the types and sources of medications used during PMET events. RESULTS The medications most commonly used were lorazepam (11%), neuromuscular blockers (10.5%), atropine (9.5%), epinephrine bolus (9%), and albuterol or levalbuterol (9%). However, 49 distinct medications were used in 53.8% of all PMET events. Of all medications requested during a PMET event, only 40% originated from an institutionally standardized emergency medication box, while an additional 35% were readily available at the patient's bedside as part of the “pharmacist PMET supply.” CONCLUSIONS A wide variety of medications are required to care for children who suffer acute in-hospital deterioration. The pharmacist's medication supply and expertise ensured immediate availability of therapies for clinical entities ranging from seizures and anaphylaxis to rapid sequence intubation, regardless of the PMET event location.
What problem does this paper attempt to address?